Dr. Husain Abbas Backs Weekly GLP-1 Weight-Loss Shots, Warns of Muscle Loss Risks
Updated
Updated · WJXT News4JAX · May 14
Dr. Husain Abbas Backs Weekly GLP-1 Weight-Loss Shots, Warns of Muscle Loss Risks
2 articles · Updated · WJXT News4JAX · May 14
Weekly GLP-1 injections such as Ozempic, Wegovy and Mounjaro have become a key alternative to bariatric surgery, and Dr. Husain Abbas called them a “lifeline” for some patients seeking weight loss.
Abbas said the drugs can aid weight management by increasing fullness and slowing digestion, with added benefits that may include heart protection and diabetes control.
Muscle loss is a major concern during rapid weight reduction, he said, urging patients to pair treatment with weightlifting and resistance training.
Nausea, vomiting, bloating, abdominal pain and electrolyte abnormalities are among the risks, making close medical supervision, blood-work monitoring and reputable prescribing sources essential.
Some patients may do best on medication alone, while others may need surgery first or a combination of surgery and GLP-1 therapy depending on how their bodies respond.
With new data showing surgery's superiority, are weight loss drugs a risky long-term health gamble?
Beyond nausea, what are the hidden health risks of popular weight loss drugs that doctors are now warning about?